These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 29745794)

  • 1. Visceral adipose tissue tracks more closely with metabolic dysfunction than intrahepatic triglyceride in lean Asians without diabetes.
    Ding C; Chan Z; Chooi YC; Choo J; Sadananthan SA; Michael N; Velan SS; Leow MKS; Magkos F
    J Appl Physiol (1985); 2018 Sep; 125(3):909-915. PubMed ID: 29745794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity.
    Fabbrini E; Magkos F; Mohammed BS; Pietka T; Abumrad NA; Patterson BW; Okunade A; Klein S
    Proc Natl Acad Sci U S A; 2009 Sep; 106(36):15430-5. PubMed ID: 19706383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ectopic fat and aerobic fitness are key determinants of glucose homeostasis in nonobese Asians.
    Chan Z; Ding C; Chooi YC; Choo J; Sadananthan SA; Sasikala S; Chang A; Michael N; Velan SS; Leow MK; Magkos F
    Eur J Clin Invest; 2019 May; 49(5):e13079. PubMed ID: 30734926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of glucose metabolism in nondiabetic, metabolically obese normal-weight Asians.
    Ding C; Chan Z; Chooi YC; Choo J; Sadananthan SA; Chang A; Sasikala S; Michael N; Velan SS; Magkos F
    Am J Physiol Endocrinol Metab; 2018 May; 314(5):E494-E502. PubMed ID: 29351481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moderate Weight Loss Improves Body Composition and Metabolic Function in Metabolically Unhealthy Lean Subjects.
    Chooi YC; Ding C; Chan Z; Choo J; Sadananthan SA; Michael N; Lee Y; Velan SS; Magkos F
    Obesity (Silver Spring); 2018 Jun; 26(6):1000-1007. PubMed ID: 29676049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes.
    Cusi K; Bril F; Barb D; Polidori D; Sha S; Ghosh A; Farrell K; Sunny NE; Kalavalapalli S; Pettus J; Ciaraldi TP; Mudaliar S; Henry RR
    Diabetes Obes Metab; 2019 Apr; 21(4):812-821. PubMed ID: 30447037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects.
    Korenblat KM; Fabbrini E; Mohammed BS; Klein S
    Gastroenterology; 2008 May; 134(5):1369-75. PubMed ID: 18355813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased whole-body adiposity without a concomitant increase in liver fat is not associated with augmented metabolic dysfunction.
    Magkos F; Fabbrini E; Mohammed BS; Patterson BW; Klein S
    Obesity (Silver Spring); 2010 Aug; 18(8):1510-5. PubMed ID: 20395947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease.
    Bril F; Barb D; Portillo-Sanchez P; Biernacki D; Lomonaco R; Suman A; Weber MH; Budd JT; Lupi ME; Cusi K
    Hepatology; 2017 Apr; 65(4):1132-1144. PubMed ID: 27981615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia.
    Amaro A; Fabbrini E; Kars M; Yue P; Schechtman K; Schonfeld G; Klein S
    Gastroenterology; 2010 Jul; 139(1):149-53. PubMed ID: 20303351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
    Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
    Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents.
    Deivanayagam S; Mohammed BS; Vitola BE; Naguib GH; Keshen TH; Kirk EP; Klein S
    Am J Clin Nutr; 2008 Aug; 88(2):257-62. PubMed ID: 18689359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin is inversely associated with intramyocellular and intrahepatic lipids in obese premenopausal women.
    Bredella MA; Torriani M; Ghomi RH; Thomas BJ; Brick DJ; Gerweck AV; Harrington LM; Miller KK
    Obesity (Silver Spring); 2011 May; 19(5):911-6. PubMed ID: 21151017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity, regional fat distribution, and syndrome X in obese black versus white adolescents: race differential in diabetogenic and atherogenic risk factors.
    Bacha F; Saad R; Gungor N; Janosky J; Arslanian SA
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2534-40. PubMed ID: 12788850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between the Bertin index to estimate visceral adipose tissue from dual-energy X-ray absorptiometry and cardiometabolic risk factors before and after weight loss.
    Karelis AD; Rabasa-Lhoret R; Pompilus R; Messier V; Strychar I; Brochu M; Aubertin-Leheudre M
    Obesity (Silver Spring); 2012 Apr; 20(4):886-90. PubMed ID: 21869764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visceral and not subcutaneous abdominal adiposity reduction drives the benefits of a 1-year lifestyle modification program.
    Borel AL; Nazare JA; Smith J; Alméras N; Tremblay A; Bergeron J; Poirier P; Després JP
    Obesity (Silver Spring); 2012 Jun; 20(6):1223-33. PubMed ID: 22262155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of insulin-like growth factor binding protein-2 with metabolic profile and hepatic fat deposition in asymptomatic men and women.
    Rauzier C; Chartrand DJ; Alméras N; Lemieux I; Larose E; Mathieu P; Pibarot P; Lamarche B; Rhéaume C; Poirier P; Després JP; Picard F
    Am J Physiol Endocrinol Metab; 2023 Jul; 325(1):E99-E105. PubMed ID: 37285597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma IGFBP-2 levels reveal heterogeneity in hepatic fat content in adults with excess visceral adiposity.
    Rauzier C; Chartrand DJ; Alméras N; Lemieux I; Larose E; Mathieu P; Pibarot P; Lamarche B; Rhéaume C; Poirier P; Després JP; Picard F
    Front Endocrinol (Lausanne); 2023; 14():1222101. PubMed ID: 37854178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: the International Study of Prediction of Intra-Abdominal Adiposity and Its Relationship With Cardiometabolic Risk/Intra-Abdominal Adiposity.
    Nazare JA; Smith JD; Borel AL; Haffner SM; Balkau B; Ross R; Massien C; Alméras N; Després JP
    Am J Clin Nutr; 2012 Oct; 96(4):714-26. PubMed ID: 22932278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous and visceral adipose tissue gene expression of serum adipokines that predict type 2 diabetes.
    Samaras K; Botelho NK; Chisholm DJ; Lord RV
    Obesity (Silver Spring); 2010 May; 18(5):884-9. PubMed ID: 20019678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.